ArticleNature communications2025
Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors.
Mark Jesus M Magbanua et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled ittrialcites it